Becton Dickinson Financial Indicators Patterns

BDX -- USA Stock  

USD 253.37  4.09  1.64%

We suggest you to use Becton Dickinson fundamental analysis to see if markets are presently mispricing the company. In plain English you can use it to find out if Becton Dickinson is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We found thirty-eight available fundamental indicators for Becton Dickinson and Company which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Becton Dickinson fundamentals including its Shares Outstanding, Net Income, Price to Earnings To Growth, as well as the relationship between Price to Book and Current Ratio . Given that Becton Dickinson has Price to Earning of 86.89X, we suggest you validate Becton Dickinson and Company prevailing market performance to make sure the company can sustain itself down the road. Use Becton Dickinson to enhance returns of your portfolios. The stock experiences large bullish trend. Check odds of Becton Dickinson to be traded at $278.71 in 30 days.
34%34%

Chance of Financial Distress

Becton Dickinson and Company has less than 34 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Becton Dickinson Company Summary

Becton Dickinson competes with Ekso Bionics, Cooper Companies, Haemonetics, and electroCore. Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey. Becton Dickinson operates under Medical Instruments Supplies classification in USA and is traded on BATS Exchange. It employs 65000 people.

Becton Dickinson Shares Owned by Institutions vs Earnings Per Share

Becton Dickinson and Company is rated below average in shares owned by institutions category among related companies. It is rated below average in earnings per share category among related companies creating about  0.03  of Earnings Per Share per Shares Owned by Institutions. The ratio of Shares Owned by Institutions to Earnings Per Share for Becton Dickinson and Company is roughly  30.60 

Becton Dickinson Systematic Risk

The output start index for this execution was twelve with a total number of output elements of twenty-seven. The Beta measures systematic risk based on how returns on Becton Dickinson correlated with the market. If Beta is less than 0 Becton Dickinson generally moves in the opposite direction as compared to the market. If Becton Dickinson Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Becton Dickinson is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Becton Dickinson is generally in the same direction as the market. If Beta > 1 Becton Dickinson moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Becton Dickinson Thematic Clasifications

Obamacare Repeal Idea
Obamacare RepealView
Cancer Fighters Idea
Cancer FightersView
Medical Equipment Idea
Medical EquipmentView
Healthcare Idea
HealthcareView
Drugs Idea
DrugsView

Becton Dickinson August 21, 2019 Opportunity Range

Check also Trending Equities. Please also try Headlines Timeline module to stay connected to all market stories and filter out noise. drill down to analyze hype elasticity.
Search macroaxis.com